#Denmark #Copenhagen #digital health #Merck #Dawn Health

Dawn Health and Merck Launch Next-Generation Digital Ecosystem for Growth Disorders

In a groundbreaking collaboration, Dawn Health and Merck have unveiled a next-generation digital ecosystem tailored specifically for treating growth disorders. This innovative platform is designed to enhance support for patients suffering from growth hormone deficiency, caregivers, and healthcare professionals. The initiative stands as a significant advancement in digital solutions for hormone deficiencies, focusing on improving accessibility, usability, and clinical assistance.

Over the past year, both companies have joined forces to evolve the core mobile application and healthcare professional portal central to this ecosystem. Built on the Dawn platform, the newly developed tools offer a more intuitive and engaging user experience. The updated mobile application merges playful, child-friendly elements with a well-structured presentation that assists caregivers effectively. Additionally, the new healthcare provider portal enhances treatment tracking and provides rapid access to clinical information, fortified with improved security and geolocation features for global scalability.

The initial release introduces several key functions. Future updates promise to expand the ecosystem with AI-powered features, such as growth predictions, personalized treatment advice, and real-time data collection via connected devices. This exciting direction hints at a future where technology plays an even greater role in the management of growth disorders.

«At Dawn Health, we are committed to reshaping digital health with solutions that genuinely impact patients' lives. This partnership with Merck embodies our ambition to create user-centered products that deliver tangible value to patients, caregivers, and healthcare professionals. Powered by the Dawn platform, this ecosystem is designed to adapt and evolve according to the care needs related to growth disorders. We are privileged to collaborate with a partner as dedicated to improving outcomes in growth disorders as Merck,» said Alexander Mandix Hansen, CEO of Dawn Health.

This partnership underscores a shared vision to rethink care through technology and set a new standard in managing growth disorders. By merging expertise from the digital health realm and the pharmaceutical industry, the Dawn Health and Merck collaboration is positioning itself at the forefront of growth disorder treatment.

About Dawn Health

Dawn Health is a global leader in digital health, specializing in the development of Software as a Medical Device (SaMD), digital therapeutics (DTx), and connected health solutions. With a focus on accelerating the market launch of digital solutions, Dawn Health’s product line drives innovation to transform the lives of individuals living with chronic diseases. By fostering close partnerships within the life sciences industry, Dawn Health creates digital health products that revolutionize patient care through an empathetic and human-centered approach.

For further information, visit Dawn Health's official website.